Trial NCT01891981

View at ClinicalTrials.gov 
Org. Study IDs: 2012-1143
Secondary IDs: NCI-2013-02207

Last trial update was posted on 2023-10-13

MeSH Interventions

Immunotoxin HA22

MeSH Conditions

Leukemia Leukemia, Lymphoid Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions


Stopping Reasons

Ph I Exempt as it did not proceed to the Phase II terminated early by the supporter

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID